Phreesia (NYSE:PHR) Insider Sells $46,039.24 in Stock

Phreesia, Inc. (NYSE:PHR) insider David Linetsky sold 2,059 shares of the firm’s stock in a transaction on Friday, October 17th. The stock was sold at an average price of $22.36, for a total value of $46,039.24. Following the completion of the transaction, the insider owned 171,829 shares in the company, valued at approximately $3,842,096.44. This trade represents a 1.18% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

David Linetsky also recently made the following trade(s):

• On Thursday, September 18th, David Linetsky sold 93 shares of Phreesia stock. The stock was sold at an average price of $23.94, for a total value of $2,226.42.
• On Wednesday, September 17th, David Linetsky sold 1,064 shares of Phreesia stock. The stock was sold at an average price of $23.50, for a total value of $25,004.00.
• On Tuesday, September 16th, David Linetsky sold 2,165 shares of Phreesia stock. The stock was sold at an average price of $23.28, for a total value of $50,401.20.
• On Friday, August 22nd, David Linetsky sold 17,445 shares of Phreesia stock. The stock was sold at an average price of $29.73, for a total value of $518,639.85.
• On Monday, August 18th, David Linetsky sold 78 shares of Phreesia stock. The stock was sold at an average price of $29.16, for a total value of $2,274.48.

Phreesia Stock Performance

PHR stock opened at $23.52 on Friday. The company has a market cap of $1.41 billion, a P/E ratio of -55.99 and a beta of 0.68. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $32.76. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.12 and a quick ratio of 2.12. The stock’s fifty day moving average price is $25.73 and its 200-day moving average price is $25.95.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.08. The firm had revenue of $117.26 million for the quarter, compared to the consensus estimate of $116.39 million. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The company’s revenue for the quarter was up 14.9% on a year-over-year basis. During the same period last year, the business posted ($0.03) EPS. Phreesia has set its FY 2026 guidance at EPS. On average, equities analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Hedge Funds Weigh In On Phreesia

Large investors have recently made changes to their positions in the business. Cubist Systematic Strategies LLC purchased a new position in shares of Phreesia in the first quarter valued at about $774,000. Principal Financial Group Inc. purchased a new position in shares of Phreesia in the first quarter valued at about $1,623,000. Farther Finance Advisors LLC lifted its position in shares of Phreesia by 9,375.0% in the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after acquiring an additional 3,000 shares in the last quarter. Deutsche Bank AG lifted its position in shares of Phreesia by 30.6% in the first quarter. Deutsche Bank AG now owns 74,857 shares of the company’s stock valued at $1,913,000 after acquiring an additional 17,560 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its position in shares of Phreesia by 105.2% in the first quarter. Acadian Asset Management LLC now owns 225,317 shares of the company’s stock valued at $5,754,000 after acquiring an additional 115,527 shares in the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

PHR has been the topic of several analyst reports. Raymond James Financial set a $33.00 target price on Phreesia and gave the company an “outperform” rating in a research report on Friday, September 5th. JMP Securities lifted their target price on Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a research report on Monday, September 8th. Canaccord Genuity Group lifted their target price on Phreesia from $34.00 to $38.00 and gave the company a “buy” rating in a research report on Friday, September 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Phreesia in a research report on Wednesday, October 8th. Finally, Truist Financial lifted their target price on Phreesia from $35.00 to $36.00 and gave the company a “buy” rating in a research report on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Phreesia has an average rating of “Moderate Buy” and a consensus price target of $33.85.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.